BioMimetic Therapeutics to raise over $50M in stock sale ahead of their expected PMA clearance of the Augment Bone Graft

By

BioMimetic Therapeutics, Inc. Announces Commencement of Public Offering of Common Stock (Press Release)...

Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top